{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-004490","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.628970+00:00","generated_at":"2026-05-27T04:44:58.851733+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Intelligent Bio Solutions plans multilingual upgrade for drug screening system, aims to reach 4B users","bullets":["Multilingual upgrade will support languages across Americas, Europe, Asia Pacific, and Middle East, accessible to over 4 billion speakers worldwide.","Supports planned 2025 entry into US market following FDA 510(k) submission in December 2024.","Company has existing presence in 19 countries; targets safety-critical industries like construction, mining, and transport.","Drug screening market projected to reach approximately $8 billion globally by 2030."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-004490","json":"https://secwatch.observer/filing/0001493152-25-004490.json","markdown":"https://secwatch.observer/filing/0001493152-25-004490.md","text":"https://secwatch.observer/filing/0001493152-25-004490.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225004490/0001493152-25-004490-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225004490/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T04:44:58.851733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}